Tradestie Institutional Equity Comparison Engine

OKYO vs ARGX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARGX Overall Edge

ARGX Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to argenx SE American Depositary Shares (ARGX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ARGX at 27.8x Forward P/E and 31.9% operating margin (+52.1% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ARGX sits in UNCLASSIFIED (33rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARGX
OKYO N/M vs ARGX 27.8x Fwd P/E
Growth & Margin Winner ARGX
Op Margin 0.0% vs 31.9% ยท YoY +0.0% vs +52.1%
Momentum & Technical Winner ARGX
1Y -47.0% vs +1.2% ยท 52W Pos 3% vs 64%
Options & Structure Winner ARGX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (33rd %ile IV)
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0
ARGX NASDAQ
argenx SE American Depositary Shares
Biological Products, (No Diagnostic Substances)
$925.70
-1.73% 1D
Market Cap $59.3B
1M Return +5.7%
1Y Return +1.21%
Forward P/E 27.8x
Unified AI Score
49.6 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OKYO -47.03% ARGX +1.21% Spread: +48.24 pp (ARGX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OKYO TTM Op. Margin: 0.0% ARGX TTM Op. Margin: 31.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs ARGX. Trailing 12-month operating profitability (OKYO 0.0% vs ARGX 31.9%) and valuation multiples (OKYO N/M vs ARGX 27.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OKYO (0) vs ARGX (10)
Institutional Metric OKYO ARGX Criterion Row Winner
Market Capitalization Scale $62.7M $59.3B Larger Scale ARGX
Trailing P/E Ratio Valuation N/M 32.6x Lower Multiple ARGX
Forward P/E Ratio Valuation N/M 27.8x Lower Multiple ARGX
Revenue Growth (YoY) Growth +0.0% +52.1% Higher Growth ARGX
Operating Margin (TTM) Profitability 0.0% 31.9% Higher Margin ARGX
Net Profit Margin Profitability 0.0% 31.7% Higher Margin ARGX
Return on Equity (ROE) Capital Efficiency -263.8% 23.6% Higher ROE ARGX
52-Week Range Position Momentum 3% ($1โ€“$3) 64% ($662โ€“$1,073) Stronger Trend ARGX
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 76% Vol 0.56ฮฒ ยท 31% Vol Lower Realized Risk ARGX
Unified Institutional Score Composite Signal 42.8 / 100 (HOLD) 49.6 / 100 (HOLD) Higher Composite ARGX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OKYO vs ARGX Buy Guide
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARGX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OKYO nor ARGX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.